Table 3

Comparison of characteristics and clinical findings between patients aged 50 years or less and patients aged more than 50 years

VariablePatients ≤50 yearsPatients >50 yearsp Value
n=37n=46
Caucasian, n (%)22 (59.5)40 (87)0.009
Ophthalmological findings, n (%)
 Intraocular manifestations0.69
  Anterior9 (24.3)7 (15.2)
  Anterior Intermediate3 (8.1)7 (15.2)
  Intermediate2 (5.4)3 (6.5)
  Posterior3 (8.1)6 (13)
  Panuveitis20 (54.1)23 (50)
 Chronic form20 (60.6)34 (79.1)0.13
 Bilateral involvement29 (78.4)33 (71.7)0.66
 Granulomatous uveitis20 (54.1)27 (60)0.75
 Elevated IOP1 (2.7)3 (6.5)0.63
 CME11 (29.7)21 (47.7)0.15
 PMC10 (27)17 (38.6)0.39
Serum markers, n (%)
 High ACE23 (65.7)27 (58.7)0.68
 Normal ACE12 (34.3)19 (41.3)
 High lysozyme level22 (81.5)30 (85.7)0.73
 Normal lysozyme level5 (18.5)5 (14.3)
Chest imaging, n (%)
 Abnormal chest X-rays29 (82.9)20 (46.5)0.002
 Abnormal chest CTs33 (91.7)40 (90.9)1
  • CME, chronic macular oedema; elevated IOP: chronically elevated intraocular pressure >21 mm Hg resulting from damage of angle; PMC, peripheral multifocal choroiditis.